Abstract
A combination of data obtained by classical epidemiological techniques with insights gained from the analysis of the population biology of Neisseria meningitidis have proved to be critical in understanding the spread of menin-gococcal disease. This is a consequence of the natural history and evolution of this bacterium, which, despite its fearsome reputation as an aggressive pathogen (1), is ordinarily a harmless commensal inhabitant of the nasopharynx of adult humans (2). Further, it has been established that “natural,” (that is to say, carried) populations of meningococci are highly diverse, with a minority of genotypes (the “hyperinvasive lineages”) being responsible for the majority of disease (3). Finally, it is known that distinct hyperinvasive lineages tend to be associated with particular epidemiological manifestations of meningococcal disease (4) and some are especially associated with severe disease (the “hyper-virulent” lineages) (5). These complexities have important implications for public-health interventions, as different disease epidemiologies, caused by genetically diverse meningococci, require distinct approaches to public-health management. For example, the public-health response necessary to combat large-scale meningococcal-disease outbreaks in Africa (6) is different from that required during an institutional disease outbreak in Europe and North America, and prolonged geographical outbreaks in these countries require a different response again (7). In recognition of the importance of the multi-disciplinary approach necessary to establish these insights, this section contains chapters ranging from outbreak management through surveillance and isolate characterization techniques to phylogenetic methods. Together the chapters provide the methodologies necessary for monitoring, understanding, and reacting to the spread of meningococcal disease.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Peltola H. (1983) Meningococcal disease: still with us. Rev. Infect. Dis. 5, 71–91.
Broome C. V. (1986) The carrier state: Neisseria meningitidis. J. Antimicrob. Chemother. 18(Suppl. A), 25–34.
Caugant D. A., Froholm L. O., Sacchi C. T., and Selander R. K. (1991) Genetic structure and epidemiology of serogroup B Neisseria meningitidis, in Neisseriae 1990 (Achtman M., Kohl P., Marchal C., Morelli G., Seiler A., and Thiesen B., eds.), Walter de Gruyter, Berlin, pp. 37–42.
Maiden M. C. J. and Feavers I. M. (1995) Population genetics and global epidemiology of the human pathogen Neisseria meningitidis, in Population Genetics of Bacteria (Baumberg S., Young J. P. W., Wellington E. M. H., and Saunders J. R., eds.), Cambridge University Press, Cambridge, UK, pp. 269–293.
Whalen C. M., Hockin J. C., Ryan A., and Ashton F. (1995) The changing epidemiology of invasive meningococcal disease in Canada, 1985 through 1992. Emergence of a virulent clone of Neisseria meningitidis. JAMA 273, 390–394.
Hart C. A., Cuevas L. E., Marzouk O., Thomson A. P., and Sills J. (1993) Management of bacterial meningitis. J. Antimicrob. Chemother. 32(Suppl. A), 49–59.
Begg N. (1995) Outbreak management, in Meningococcal Disease (Cartwright K. A. V., ed.), John Wiley and Sons, Sons, Chichester, UKhichester, UK, pp. 286–305.
Cartwright K. A. V. (1995) Meningococcal Disease. John Wiley & Sons, Sons, Chichester, UKhichester, UK.
Branham S. E. (1953) Serological relationships among meningococci. Bact. Rev. 17, 175–188.
Vedros N. A. (1987) Development of meningococcal serogroups, in Evolution of Meningococcal Disease; vol. II (Vedros N. A., ed.), CRC Press Inc., Boca Raton, FL, pp. 33–37.
Frasch C. E., Zollinger W. D., and Poolman J. T. (1985) Serotype antigens of Neisseria meningitidis and a proposed scheme for designation of serotypes. Rev. Infect. Dis. 7, 504–510.
Moore P. S. and Broome C. V. (1994) Cerebrospinal meningitis epidemics. Sci. Am. 271, 24–31.
Lapeyssonnie L. (1963) La meningite cerebrospinale en Afrique. Bull. WHO 28(Suppl.), 53–114.
Schwartz B., Moore P. S., and Broome C. V. (1989) Global epidemiology of meningococcal disease. Clin. Microbiol. Rev. 2, 118–124.
Achtman M. (1991) Clonal properties of meningococci from epidemic meningitis. Trans. R. Soc. Trop. Med. Hyg. 85(Suppl. 1), 24–31.
Achtman M. (1990) Molecular epidemiology of epidemic bacterial meningitis. Rev. Med. Microbiol. 1, 29–38.
Wang J.-F., Caugant D. A., Li X., Hu X., Poolman J. T., Crowe B. A., and Achtman M. (1992) Clonal and antigenic analysis of serogroup A Neisseria meningitidis with particular reference to epidemiological features of epidemic meningitis in China. Infect. Immun. 60, 5267–5282.
Mohammed I., Nasidi A., Alkali A. S., Garbati M. A., Ajayi-Obe E. K., Audu K. A., et al. (2000) A severe epidemic of meningococcal meningitis in Nigeria, 1996. Trans. R. Soc. Trop. Med. Hyg. 94, 265–270.
Moore P. S., Harrison L. H., Telzak E. E., Ajello G. W., and Broome C. V. (1988) Group A meningococcl carriage in travelers returning from Saudi Arabia. JAMA 260, 2686–2689.
Popovic T., Sacchi C. T., Reeves M. W., Whitney A. M., Mayer L. W., Noble C. A., et al. (2000) Neisseria meningitidis serogroup W135 isolates associated with the ET-37 complex [letter]. Emerg. Infect. Dis. 6, 428–429.
Hansman D. (1983) Meningococcal disease in South Australia: incidence and serogroup distribution 1971-1980. J. Hyg. 90, 49–54.
Kaczmarski E. B. (1997) Meningococcal infections in England and Wales. Com-muni. Dis. Rep. Rev. 7, R55–R59.
Barquet N., Domingo P., Cayla J. A., Gonzalez J., Rodrigo C., Fernandez-Viladrich P., et al. (1999) Meningococcal disease in a large urban population (Barcelona, 1987-1992): predictors of dismal prognosis. Barcelona Meningococcal Disease Surveillance Group. Arch. Intern. Med. 159, 2329–2340.
Krizova P., Musilek M., and Kalmusova J. (1997) Development of the epide-miological situation in invasive meningococcal disease in the Czech Republic caused by emerging Neisseria meningitidis clone ET-15/37. Cent. Eur. J. Public Health 5, 214–218.
Kremastinou J., Tzanakaki G., Velonakis E., Voyiatzi A., Nickolaou A., Elton R. A., et al. (1999) Carriage of Neisseria meningitidis and Neisseria lactamica among ethnic Greek school children from Russian immigrant families in Athens. FEMS Immunol. Med. Microbiol. 23, 13–20.
Caugant D. A., Mocca L. F., Frasch C. E., Froholm L. O., Zollinger W. D., and Selander R. K. (1987) Genetic structure of Neisseria meningitidis populations in relation to serogroup, serotype, and outer membrane protein pattern. J. Bacteriol. 169, 2781–2792.
Caugant D. A., Froholm L. O., Bovre K., Holten E., Frasch C. E., Mocca L. F., et al. (1987) Intercontinental spread of Neisseria meningitidis clones of the ET-5 complex. Antonie van Leeuwenhoek J. Microbiol. 53, 389–394.
Maiden M. C. J., Bygraves J. A., Feil E., Morelli G., Russell J. E., Urwin R., et al. (1998) Multilocus sequence typing: a portable approach to the identification of clones within populations of pathogenic microorganisms. Proc. Natl. Acad. Sci. USA 95, 3140–3145.
Caugant D. A., Kristiansen B. E., Froholm L. O., Bovre K., and Selander R. K. (1988) Clonal diversity of Neisseria meningitidis from a population of asymptomatic carriers. Infect. Immun. 56, 2060–2068.
Maiden M. C. J. (1993) Population genetics of a transformable bacterium: the influence of horizontal genetical exchange on the biology of Neisseria meningitidis. FEMS Microbiol. Lett. 112, 243–250.
Gupta S., Maiden M. C. J., Feavers I. M., Nee S., May R. M., and Anderson R. M. (1996) The maintenance of strain structure in populations of recombining infectious agents. Nat. Med. 2, 437–442.
Bygraves J. A. and Maiden M. C. J. (1992) Analysis of the clonal relationships between strains of Neisseria meningitidis by pulsed field gel electrophoresis. J. Gen. Microbiol. 138, 523–531.
Parkhill J., Achtman M., James K. D., Bentley S. D., Churcher C., Klee S. R., et al. (2000) Complete DNA sequence of a serogroup A strain of Neisseria meningitidis Z2491. Nature 404, 502–506.
Tettelin H., Saunders N. J., Heidelberg J., Jeffries A. C., Nelson K. E., Eisen J. A., et al. (2000) Complete genome sequence of Neisseria meningitidis serogroup B strain MC58. Science 287, 1809–1815.
Carrol E. D., Thomson A. P., Shears P., Gray S. J., Kaczmarski E. B., and Hart C. A. (2000) Performance characteristics of the polymerase chain reaction assay to confirm clinical meningococcal disease. Arch. Dis. Child 83, 271–273.
Pollard A. J. and Levin M. (2000) Vaccines for prevention of meningococcal disease. Pediatr. Infect. Dis. J. 19, 333–444.
Gotschlich E. C., Goldschneider I., and Artenstein M.S. (1969) Human immunity to the meningococcus IV. Immunogenicity of group A and group C meningococcal polysaccharides. J. Exp. Med. 129, 1367–1384.
Finne J., Leinonen M., and Makela P.H. (1983) Antigenic similarities between brain components and bacteria causing meningitis: implications for vaccine development and pathogenesis. Lancet ii, 355–357.
Bjune G., Closs O., Froholm L. O., Gronnesby J. K., Hoiby E. A., and Nokleby H. (1991) Design of clinical trials with an outer membrane vesicle vaccine against systemic serogroup B meningococcal disease in Norway. NIPH. Ann. 14, 81–91.
de Moraes J. C., Perkins B. A., Camargo M. C., Hidalgo N. T., Barbosa H. A., Sacchi C. T., et al. (1992) Protective efficacy of a serogroup B meningococcal vaccine in Sao Paulo, Brazil. Lancet 340, 1074–1078.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2001 Humana Press Inc., Totowa, NJ
About this protocol
Cite this protocol
Maiden, M.C.J., Begg, N.T. (2001). Overview: Epidemiology, Surveillance, and Population Biology. In: Walker, J.M., Pollard, A.J., Maiden, M.C.J. (eds) Meningococcal Disease. Methods in Molecular Medicine™, vol 67. Humana Press. https://doi.org/10.1385/1-59259-149-3:121
Download citation
DOI: https://doi.org/10.1385/1-59259-149-3:121
Publisher Name: Humana Press
Print ISBN: 978-0-89603-849-3
Online ISBN: 978-1-59259-149-7
eBook Packages: Springer Protocols